- Home
- SPB vs COLL Comparison
SPB vs COLL Comparison
Compare SPB & COLL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | SPB | COLL |
|---|---|---|
| Founded | 1906 | 2002 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Industrial Machinery/Components | Biotechnology: Pharmaceutical Preparations |
| Sector | Miscellaneous | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.4B | 1.5B |
| IPO Year | 1994 | 2015 |
Fundamental Metrics
Financial Performance| Metric | SPB | COLL |
|---|---|---|
| Price | $75.73 | $36.92 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 5 | 6 |
| Target Price | ★ $82.40 | $50.83 |
| AVG Volume (30 Days) | ★ 370.2K | 364.8K |
| Earning Date | 05-07-2026 | 05-28-2026 |
| Dividend Yield | ★ 2.47% | N/A |
| EPS Growth | ★ N/A | N/A |
| EPS | 1.21 | ★ 1.73 |
| Revenue | ★ $3,802,100,000.00 | $780,567,000.00 |
| Revenue This Year | $1.78 | $6.07 |
| Revenue Next Year | $1.85 | N/A |
| P/E Ratio | $62.89 | ★ $21.50 |
| Revenue Growth | 20.86 | ★ 23.62 |
| 52 Week Low | $49.99 | $23.23 |
| 52 Week High | $80.42 | $50.79 |
Technical Indicators
Market Signals| Indicator | SPB | COLL |
|---|---|---|
| Relative Strength Index (RSI) | 54.97 | 21.00 |
| Support Level | $74.72 | $34.30 |
| Resistance Level | $80.42 | $39.85 |
| Average True Range (ATR) | 2.32 | 1.60 |
| MACD | -0.77 | -0.84 |
| Stochastic Oscillator | 26.90 | 7.59 |
Price Performance
Historical ComparisonAbout SPB Spectrum Brands Holdings Inc.
Spectrum Brands Holdings Inc is consumer products and home essentials company. The company is a supplier of consumer batteries, residential locksets, residential builders' hardware, grooming products and personal care products. The company manages the businesses in product-focused segments; Home and Personal Care, global Pet Care, and Home and Garden. The Company manufactures, markets and distributes its products globally in the North America, Europe, Middle East & Africa, Latin America, and Asia-Pacific.
About COLL Collegium Pharmaceutical Inc.
Collegium Pharmaceutical Inc is a specialty pharmaceutical company. The company is engaged in developing and planning to commercialize abuse-deterrent products that incorporate its patented DETERx platform technology for the treatment of chronic pain and other diseases. The DETERx platform technology is designed to maintain the extended-release and safety profiles of abused drugs in the face of various methods including chewing, crushing, and dissolving. Its product portfolio includes Jornay, Xtampza ER, which is an abuse-deterrent, extended-release, oral formulation of oxycodone; and Nucynta Products, which are extended-release and immediate-release formulations of tapentadol; Belbuca, and Symproic.